Beth Israel Lahey Health’s CEO had a vision. It’s finally paying off.

Dr. Dan Barouch, director of the Center for Virology and Vaccine Research and a researcher at Beth Israel Deaconess Medical Center, was excited about what the Dana-Farber collaboration would mean for the future, from an greater number of patients coming to BI, to possibly enhanced research opportunities.

“Time will tell, but [the deal] likely will increase the profile of BILH as a health care network, once the collaboration with Dana-Farber is completed,“ Barouch said. Read Full Article…